Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC

Conditions:   Non-small Cell Lung Cancer;   Leptomeningeal Disease;   Central Nervous System Metastases Intervention:   Drug: Afatinib Sponsor:   National Cancer Centre, Singapore Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials